NOS3 gene rs1799983 polymorphism and incident dementia in elderly stroke survivors

Neurobiol Aging. 2011 Mar;32(3):554.e1-6. doi: 10.1016/j.neurobiolaging.2010.06.012. Epub 2010 Aug 5.

Abstract

Stroke is a major risk factor for the development of dementia in the elderly. It is unclear which genes influence risk of delayed dementia after stroke. We tested a single nucleotide polymorphism (SNP) in endothelial nitric oxide synthase (NOS3) gene at codon 298 (single-nucleotide polymorphism rs1799983; p.Asp298Glu) in a cohort of 355 older (>75 years) stroke survivors, who had detailed cognitive assessments from 3 months poststroke, i.e., baseline when the patients were free of dementia and subsequently at annual intervals. Of these, 253 participants were genotyped for polymorphisms in NOS3 and apolipoprotein E (APOE). Our analysis showed that homozygosity for NOS3 TT rather than the GT or GG genotype was a significant factor in the development of dementia. The presence of TT genotype increased risk of incident dementia compared with GG genotype; hazard ratio, 3.14 (95% confidence interval, 1.64-5.99; p = 0.001). We hypothesize that this may be mediated by reduction of nitric oxide production and cerebral perfusion. Our findings, if replicated widely, have implications for treatments to ameliorate cognitive decline in stroke survivors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Apolipoproteins E / genetics
  • Cognition Disorders / etiology
  • Cognition Disorders / genetics
  • Cohort Studies
  • Dementia / etiology*
  • Dementia / genetics*
  • Female
  • Genetic Predisposition to Disease*
  • Genotype
  • Geriatric Assessment
  • Humans
  • Male
  • Mental Status Schedule
  • Nitric Oxide Synthase Type III
  • Polymorphism, Single Nucleotide / genetics*
  • Stroke / complications*
  • Survival

Substances

  • Apolipoproteins E
  • NOS3 protein, human
  • Nitric Oxide Synthase Type III